A major problem in the study of animal models of neurodegenerative disease is the lack of an unambiguous marker to identify dying neurons. A new method, the terminal transferase-mediated dUTP-biotin nick end labeling (TUNEL) technique involves the end labeling of fragmented DNA associated with dying cells with biotinylated nucleotides, after which cells are visualized via avidin-conjugated peroxidase. The method has been used successfully to label cells undergoing programmed death in the digestive, lymphatic, and reproductive systems and skin. TUNEL has not been applied to studies of cell death in the nervous system, and in this Pilot, we propose a series of experiments designed to investigate the validity and usefulness of this technique as a tool to enhance our understanding of neuronal cell death. Initially, we will validate the selectivity and specificity of the technique on tissues from the spinal cord of rats at embryonic day 16, a time point at which naturally occurring motor neuron death has been reported. Subsequently, we will examine three animal models of retrograde neuronal degeneration that are well established in our laboratory, one involving neonatal and the other two involving adult neurons. The studies described in this Pilot will allow us to determine the usefulness of TUNEL in identifying degenerating neurons. This strategy will then be used to investigate these issues in other models, including transgenic mice in our Alzheimer's Disease Research Center (ADRC), and eventually, to focus this approach on processes that lead to death of neurons in the human brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-14
Application #
5204510
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Xiong, Yulan; Neifert, Stewart; Karuppagounder, Senthilkumar S et al. (2018) Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc Natl Acad Sci U S A 115:1635-1640
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6
Bouhrara, Mustapha; Reiter, David A; Bergeron, Christopher M et al. (2018) Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimers Dement 14:998-1004
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Varma, Vijay R; Oommen, Anup M; Varma, Sudhir et al. (2018) Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med 15:e1002482
Wong, Dean F; Comley, Robert A; Kuwabara, Hiroto et al. (2018) Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects. J Nucl Med 59:1869-1876
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Soldan, Anja; Pettigrew, Corinne; Albert, Marilyn (2018) Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. Psychiatr Clin North Am 41:65-77
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124

Showing the most recent 10 out of 830 publications